Thus, the IRF-1/CTSS pathway could be modulated by cytokines, microRNAs, and pharmaceuticals, which mediates inflammatory pathology in radiation injury, infections, genetic disorders, and pharmacogenetic diseases. This evidence concerns the gene CTSS and infection.